Outcome of Pregnancy and Disease Course among Women with Aplastic Anemia Treated with Immunosuppression
- 6 August 2002
- journal article
- editorial
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 137 (3) , 164-172
Abstract
Aplastic anemia may develop during pregnancy and sometimes improves spontaneously after delivery. The effects of pregnancy on aplastic anemia after immunosuppressive treatment and of aplastic anemia on the outcome of pregnancy have not been described. To determine the outcome of pregnancy and the disease course among women with aplastic anemia who received immunosuppressive therapy. Retrospective multicenter study. Twelve centers participating in the European Group for Blood and Marrow Transplantation. 36 women who received immunosuppressive therapy to treat aplastic anemia. Outcomes of pregnancy and aplastic anemia and blood counts before, during, and after delivery. The 36 pregnancies resulted in 34 live births (one set of twins), 2 elective abortions, and 1 spontaneous abortion. Of the 36 pregnancies, 22 were uncomplicated and 14 involved medical complications. Seven pregnancies (19%) were complicated by relapse of aplastic anemia, and 5 patients without relapse (14%) needed transfusions during delivery. After delivery, 3 of the 7 patients who had relapse recovered spontaneously and 3 recovered after retreatment. One patient who did not respond to treatment died of aplastic anemia. A woman with aplastic anemia and paroxysmal nocturnal hemoglobinuria had a fatal cerebral thrombosis after delivery. Women with uneventful pregnancies had better prepregnancy remission status (8 complete and 11 partial remissions) and a higher median platelet count (146 × 109 cells/L) than did women with complicated pregnancies (2 complete remissions, 8 partial remissions, and 4 cases of paroxysmal nocturnal hemoglobinuria; median platelet count, 92 × 109 cells/L). Successful pregnancy with normal outcome is possible in women with aplastic anemia previously treated with immunosuppression. Complications appear to be more likely in patients with low platelet counts and paroxysmal nocturnal hemoglobinuria–associated aplastic anemia. *For a list of centers that participated in the Study of the European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party, see Appendix.Keywords
This publication has 29 references indexed in Scilit:
- Pregnancy in Irish renal transplant recipients in the cyclosporine eraIrish Journal of Medical Science (1971 -), 2000
- Platelet count at term pregnancy: a reappraisal of the thresholdObstetrics & Gynecology, 2000
- Developmental well-being in offspring of women receiving cyclosporine post-renal transplantTransplantation Proceedings, 1999
- Pregnancy and severe aplastic anaemia: causal relation or coincidence?British Journal of Haematology, 1998
- Comparison of the Differential Distribution of Leukocytes in Preeclampsia versus Uncomplicated PregnancyGynecologic and Obstetric Investigation, 1998
- Mechanism and management of treatment-related gonadal failure in recipients of high dose chemoradiotherapyBlood Reviews, 1995
- Leucocyte count and leucocyte differential in smoking and non-smoking females during pregnancyEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1994
- Thrombocytopenia at delivery: A prospective survey of 6715 deliveriesAmerican Journal of Obstetrics and Gynecology, 1990
- Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT* SAA Working PartyBritish Journal of Haematology, 1988
- Aplastic anaemia in pregnancy remitting after abortion.BMJ, 1968